Skip to main content
. 2022 Jul 19;40(3):111126. doi: 10.1016/j.celrep.2022.111126

Figure 4.

Figure 4

Innate immune cell profile in early-treated infants

Proportion of ILC1, ILC2, and ILC3 (A) or DC1, DC2/3, and plasmacytoid dendritic cells (pDCs) (B) and of monocyte populations (C) within all PBMCs at weeks 0 (n = 11), 12/24 (n = 12), and 72/84 (n = 18) in early-treated HIV-1-infected infants (EIT) and at weeks 0 (n = 12) and 12/24 (n = 4) in HIV-1-negative infants. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; Kruskal Wallis test with post-hoc Dunn’s test and Mann Whitney U test adjusted for multiple testing.